Gilead ensures HIV drugs reach marginalized groups by using data, local partners - S&P Global

Retrieved on: 2022-03-21 17:19:23

Tags for this article:

Hepatotoxins

Life Sciences

Prevention of HIV/AIDS

Biotechnology

Health

Gilead Sciences

Management of HIV/AIDS

Epidemiology of HIV/AIDS

Emtricitabine/tenofovir

Access to medicines

Gilead Sciences Inc.

United States

Click the tags to see associated articles and topics

Gilead ensures HIV drugs reach marginalized groups by using data, local partners - S&P Global. View article details on HISWAI: https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/gilead-ensures-hiv-drugs-reach-marginalized-groups-by-using-data-local-partners-69416511

Excerpt

S&P Global Market Intelligence spoke to Gilead's senior vice president of public affairs, Korab Zuka, about the pharmaceutical company's medicines ...

Article found on: www.spglobal.com

View Original Article